Movement Alert｜Guardant Health Inc. Falls 5.79% in Pre-Market Trading, Litigation Overhang Offsets Earnings Beat

Market Focus11-06

On November 6, Guardant Health Inc. fell 5.79% in Pre-Market Trading, trading at $144.0/share, with turnover of $1.42 million.

The move followed a mixed update: the company reported quarterly adjusted EPS of $(0.29) and revenue of $361.0 million, both ahead of expectations, and raised full-year revenue guidance to $1.36 billion-$1.37 billion.

However, the market remained focused on the duplex sequencing patent dispute. A prior ruling left intact a willful infringement finding, with damages, accrued royalties and interest exceeding $245.2 million, while covered products and services are subject to a 6% royalty on sales from June until patent expiry. The company also widened its full-year free cash flow burn outlook to $205 million-$220 million from $195 million-$205 million, reinforcing concern that legal and cash-flow pressures could outweigh the revenue beat.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment